Skip to main content

Table 2 Prescriptions for osteoporosis medicines for patients with recorded diagnoses of osteoporosis 2012–17

From: Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice

 

Number of patients (n = 25,188)

%

Any osteoporosis medicine

19,268

76.5%

Bisphosphonatea

11,684

46.4%

Denosumab

11,762

46.7%

Otherb

2673

10.6%

No record of osteoporosis medicine

5920

23.5%

  1. aBisphosphonate includes alendronic acid, clodronic acid, ibandronic acid, pamidronic acid, risedronic acid, zoledronic acid, etidronic acid, tiludronic acid (either singly or in combination)
  2. bOther includes strontium ranelate, tibolone, raloxifene, and teriparatide
Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us